Skip to content

Sarcopenia: revised European consensus on definition and diagnosis

Alfonso José Cruz-Jentoft, Gülistan Bahat, Jürgen Martin Bauer, Yves Boirie‌, Olivier Bruyère, Tommy Cederholm, Cyrus C. Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, Stéphane Michel Schneider, Cornel Christian Sieber, Eva Topinková, Maurits F. J. Vandewoude, Marjolein Visser, Mauro Musa Zamboni, Ivan Bautmans, Jean‐Pierre Baeyens, Matteo Cesari, Antonio Cherubini, John А. Kanis, Marcello Giuseppe Maggio, Finbarr C. Martin, Jean‐Pierre Michel, Kaisu Hannele Pitkälä, Jean‐Yves Reginster, René Rizzoli, Dolores Sánchez‐Rodríguez, Jos M. G. A. Schols

Age and Ageing · 2018 · 13,730 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Cruz-Jentoft, A. J., Bahat, G., Bauer, J. M., Boirie‌ Y., Bruyère, O., Cederholm, T., Cooper, C. C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinková, E., Vandewoude, M. F. J., Visser, M., Zamboni, M. M., EWGSOP2, W. G. for the E. W. G. on S. in O. P. 2 (EWGSOP2), and the E. G. for, Bautmans, I., Baeyens, J., … Schols, J. M. G. A. (2018). Sarcopenia: revised european consensus on definition and diagnosis. Age and Ageing, 48(1), 16–31. https://doi.org/10.1093/ageing/afy169

In text: (Cruz-Jentoft et al., 2018)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives: to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations: sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions: EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.

  1. Frailty in Older Adults: Evidence for a Phenotype2001
  2. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons1991
  3. Studies of Illness in the Aged1963
  4. Sarcopenia: European consensus on definition and diagnosis2010
  5. A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission1994

Metadata from OpenAlex (CC0). Citations are generated from the published record.